arrow
S

Sara Gagno

centro di riferimento oncologico di aviano (cro), irccs
H指数:15
被引数:725

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients’ Sex

伊马替尼治疗药物监测在真实世界意大利胃肠间质瘤队列中的临床有效性和患者性别的作用

2026-08-110
OA
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients

LC-MS/MS法用于前列腺癌患者阿比特龙、达罗他胺、阿帕他胺、恩扎卢他胺及其代谢物的治疗药物监测

2026-03-290
OAAI
Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devices

使用干血斑进行伊马替尼和诺利替尼治疗药物监测:分析验证与临床验证,以及体积收集装置的性能比较

2025-04-010
PRE
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy
2020-08-014
PREAI
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine
2020-02-0112
PREAI
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

基于DPYD的药物遗传学测试预测对氟嘧啶的严重毒性的临床有效性

2015-07-1474
OAAI